Dr. K. Kiran Kumar
MD, DNB (Radiation Therapy) (Radiation Oncology)
Sr. Consultant Radiation Oncologist
Languages:
English, Hindi, Telugu
English, Hindi, Telugu
Med Reg No:
46981
46981
Day time OPD:
MON - SAT : 12:00 PM - 04:00 PM
Location:
Hitec CitySomajiguda
Dr. K. Kiran Kumar is a Consultant Radiation Oncologist at Yashoda Hospitals, Somajiguda, with over 15 years of experience.
Educational Qualifications
- MD, DNB (Radiation Therapy)
Experience
- 2008-Present: Consultant Radiation Oncologist, Yashoda Hospitals, Somajiguda
- 2007-2008: Registrar, Department of Radiation Oncology
Services offered
- Brachytherapy (Internal Radiation Therapy)
- External Beam Radiation for Prostate Cancer
- Radiation Oncology
- Advanced Techniques (SBRT, IMRT, IGRT)
- Cancer Screening (Preventive)
- SBRT/SABR (Stereotactic Body Radiotherapy) for Cancerous Tumours
- Stereotactic Radiosurgery (SRS) for Brain & Spine Tumours
- External Beam Radiotherapy (EBRT)
- Image Guided Radiotherapy (IGRT)
- Teleradiotherapy
- Accelerated Partial Breast Radiotherapy
- Hormone Therapy for Breast Cancer
- Hormone Therapy for Prostate Cancer
- Pap Smear
Special Interest and Expertise
- Rapid Arc Technique/SRS/SRT
- ARIO
- IMA
- ESMO
- Principal Investigator in Trial no 1200.161, Trial title-A randomized, open-label, phase III study to evaluate the efficacy and safety of oral afatinib versus intravenous methotrexate in patients with recurrent and/or metastatic head and neck squamous cell carcinoma who have progressed after platinum-based therapy
- Principal Investigator trial number: 1200:131 Trial title-LUX-Head and Neck 2: randomised, double blind, placebo-controlled, phase III study to evaluate the efficacy and safety of afatinib as adjuvant therapy after chemo-radiotherapy in primary unresected patients with stage III, IVa, or IVb loco-regionally advanced head and neck squamous cell carcinoma
- Title: P276-00/64/11 A Multicenter, Phase II/III study to assess radiation induced mucositis in subjects with locally advanced squamous cell carcinoma of the head and neck, administered cisplatin and radiation with or without P276-00
- Title NETU08-18: A phase III multicenter, randomized, double-blind, double-dummy, active-controlled, parallel group study of the efficacy and safety of oral netupitant administered in combination with palonosetron and dexamethasone compared to oral palonosetron and dexamethasone for the prevention of nausea and vomiting in cancer patients receiving moderately emetogenic chemotherapy
- Title: PALO10-01: Single dose, multicenter, randomized, double-blind, double-dummy, parallel group study to assess the efficacy and safety of oral palonosetron 0.50 mg compared to I.V palonosetron 0.25mg administered with dexamthasone for the prevention of chemotherapy-induced nausea and vomiting in cancer patients receiving highly emetogenic cisplatin-based chemotherapy
Media
Blogs by Dr. K. Kiran Kumar
Testimonial for Dr. K. Kiran Kumar
Mr. Abdul Shafie
Procedure: Mycosis Fungoides
Patient Location: Sudan
I am facing problems with mycosis fungoides and it affected my skin, the rash...
Appointment
Second Opinion
WhatsApp
Call
More
